Literature DB >> 2430547

Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters.

I A Koelma, M Nap, S Huitema, R A Krom, H J Houthoff.   

Abstract

For the evaluation of differential diagnostic parameters, hepatocellular carcinoma (HCC, n = 26), liver cell adenoma (n = 4), focal nodular hyperplasia (n = 8), and secondary liver tumors (n = 15) were studied with histologic and immunohistochemical methods. The study was performed on formalin-fixed, paraffin-embedded tissue sections, and, in some cases, also on frozen sections. The diagnostic contribution of the demonstration of alpha-fetoprotein, alpha-antitrypsin, hepatitis B surface antigen, carcinoembryonic antigen (CEA), and biliary glycoprotein I (BGPI), compared with routine hematoxylin-eosin and reticulin stains was evaluated. For the differentiation between HCC, adenoma, and focal nodular hyperplasia, immunohistochemistry contributed less than the strict application of histologic criteria. Immunohistochemistry of CEA and BGPI, however, appeared to be of help in differentiating between primary and secondary liver tumors as follows: CEA is consistently absent in liver cell tumors, while a bile canalicular staining pattern was seen in 80% of HCC due to the presence of BGPI reactivity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2430547

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  8 in total

1.  Carcinoembryonic antigen and lectin binding in the bile canalicular structures of hepatocellular carcinoma.

Authors:  R Machinami; Y Oono
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

2.  Usefulness of novel imaging modalities in diagnosis of focal nodular hyperplasia of the liver.

Authors:  Y Nishigaki; E Tomita; Y Matsuno; K Goto; T Ohnishi; Y Tanaka; H Iwai; H Asano; I Yasuda; K Nagura; T Wakahara; T Yamada
Journal:  J Gastroenterol       Date:  1997-10       Impact factor: 7.527

3.  Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors.

Authors:  A E Wennerberg; M A Nalesnik; W B Coleman
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

4.  Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma.

Authors:  C Röcken; J Licht; A Roessner; S Carl-McGrath
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

5.  Sigmoid colon metastasis from hepatocellular carcinoma.

Authors:  Dong Jun Yoo; Young Hwa Chung; Yoon Seon Lee; Sung Eun Kim; Young Joo Jin; Yu Mi Lee; Mi Jung Kim
Journal:  Korean J Hepatol       Date:  2010-12

6.  Well-differentiated hepatocellular carcinoma associated with long-term survival. Report of two cases.

Authors:  M Loda; A E Mendoza; C O'Hara; J M Crawford; M Federman; H Goodman
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

7.  Impact of a single-day multidisciplinary clinic on the management of patients with liver tumours.

Authors:  J Zhang; M N Mavros; D Cosgrove; K Hirose; J M Herman; S Smallwood-Massey; I Kamel; A Gurakar; R Anders; A Cameron; J F H Geschwind; T M Pawlik
Journal:  Curr Oncol       Date:  2013-04       Impact factor: 3.677

8.  Paraganglioma-Like Adenomas of the Thyroid (PLAT): Incidental Lesions with Unusual Features in a Patient with Nodular Goiter.

Authors:  N. Peter Libbey; Mitzi K. Hemstreet; Janet R. Butmarc; Lance M. Tibbetts; Joseph R. Tucci
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.